Recombinant Mouse Antibody (G17. 12) is capable of binding to PfMSP1-19, expressed in Chinese Hamster Ovary cells (CHO). G17. 12 antibody recognises a discontinuous epitope comprising 13 residues on the first epidermal growth factor (EGF)-like domain of PfMSP1-19.
Figure 1 PfMSP119 production in the pPM121 transformed plants as measured by sandwich ELISA.
Two different monoclonal antibodies, G.17.12 and 2F.10 were used in the experiment. (A) Plant extracts crossreacted with monoclonal antibody G.17.12. C, Untransformed plants; 2, 4, 6, 12 are the transformed plants which were assayed for the PfMSP119 production in the experiment. (B) Plant extracts crossreacted with monoclonal antibody 2F.10. C: Untransformed plants; 2, 4, 6, 12 are the transformed plants, which were assayed for the PfMSP119 production in the experiment.
Ghosh, S., Malhotra, P., Lalitha, P. V., Guha-Mukherjee, S., & Chauhan, V. S. (2002). Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP119), a potential malaria vaccine candidate, in tobacco. Plant Science, 162(3), 335-343.
Figure 2 Immunoblot detection of PfMSP119 protein in transgenic tobacco plants.
All the plant extracts (transformed and untransformed plants) having 5 mg of total soluble protein. (A) Cross-reactivity of plant derived PfMSP119 protein with polyclonal antibody raised in rabbit against bacterial (E. coli ) PfMSP119 protein. Lane 1 and 4, extracts from plant numbers 4 to 6, respectively. Lane 2 and 5, extract from untransformed plants. Lane 7, bacterial protein (E. coli ). Lane 8, Gibco BRL protein marker. Lane 3 and 6, blank. (B) Cross-reactivity of transgenic plant derived PfMSP119 with monoclonal antibody G17.12. Lane 1, bacterial protein (E. coli ). Lane 2, extract from plant number 6 (containing 5 mg of total soluble protein). Lane 3, untransformed plant extract.
Ghosh, S., Malhotra, P., Lalitha, P. V., Guha-Mukherjee, S., & Chauhan, V. S. (2002). Expression of Plasmodium falciparum C-terminal region of merozoite surface protein (PfMSP119), a potential malaria vaccine candidate, in tobacco. Plant Science, 162(3), 335-343.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-101 | Recombinant Mouse Anti-PfMSP1-19 Antibody Fab Fragment (G17.12) | ELISA, WB, BL | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBW-101 | Recombinant Mouse Anti-PfMSP1-19 Antibody scFv Fragment (G17.12) | ELISA, WB, BL | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-014CT | Recombinant Mouse Anti-Plasmodium falciparum MSP1 Antibody | ELISA, WB |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0423-XY19 | Human Anti-MSP1 Recombinant Antibody (clone D3) | ELISA, IF | Human IgG |
VS-0423-XY20 | Human Anti-MSP1 Recombinant Antibody (clone C1) | ELISA, IF | Human IgG |
VS-0423-XY21 | Human Anti-MSP1 Recombinant Antibody (clone D4) | ELISA, IF | Human IgG |
There are currently no Customer reviews or questions for PABW-101. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.